The Pharmaceutical Industry

i a) - b) (- & - 1) to a ) to is in of % 003 466.3 003, 64 1 is to in R&D 004 a to a 0 to by of of a on of in on a up of s on of in a or at to of on be 004, a 4 s to of by s is to to 1.2 S 004 005, 50 of or of to DA on as - on of s s 002 4% & 7% 3% 3% 1% 0% % % % 2003 004 D r u g M a k e r Pu r p o s e* * Sa l e s ($ B i l l i o n s )% G r o w R a i p i t o r P f i z e r C h o l e s t e r o l 1 0 . 3 14Z o c o r M e r c k C h o l e s t e r o l 6 . 1 y p r e x a E l i L i l l y A n t i p s y c h o t i c 4 . 8 13N o r v a s c P f i z e r H y p e r t e n s i o n 4 . 5 7P r o c r i t / E p r e x J o h n s o n & J o h n s o n A n e m i a 4 13P r e v a c i d A b b o t t & T a k e d a S t o m a c h a c i d 4 0N e x i u m A s t r a Z e n e c a S t o m a c h a c i d 3 . 8 62P l a v i x B r i s t o l M y e r s C a r d i o v a s c u l a r D i s e a s e 3 . 7 40S e r e t i d e / A d v a i r G l a x o K l i n e S m i t h A s t h m a 3 . 7 40Z o l o f t P f i z e r A n t i d e p r e s s a n t 3 . 4 11$ 4 8 . 3 0 14%T o ta l*MS to G $G $A $ $ 2, 2004 2003 004 003 ($ % $) % ) 9% 11% 5% 8% % 14% 1% 3% % 12% % 6% $00% 9% a of at to a as a a of to be to in in to a on of to of of on to is of is to (& on of of is by (2004) 0 - 15 800 to a to on : to a of to : 00 or it to : on of (2004) by &D in of of in to &D &D (R&D &D (&D as a % 003 $27,407 $5,808 $33,215 2002 $25,655 $5,357 $31,012 2001 $23,502 $6,221 $29,773 2000 $21,364 $4,667 $26,031 1999 $18,471 $4,220 $22,691 1998 $17,128 $3,839 $20,997 1997 $15,466 $3,492 $18,958 1996 $13,627 $3,279 $16,906 1995 $11,874 $3,334 $15,207 1994 $11,102 $2,348 $13,449 &D :2004) $ 1 3 . 9$ 1 5 . 7$ 1 9 . 1$ 2 5 . 3$ 2 1 . 2$0$5$10$15$20$25$301999 2000 2001 2002 2003$i re c t -t o -c o n s u m e r a d v e rt i s i n gO f f i c e , h o s p i t a l , & j o u rn a l p ro m o t i o n sR e t a i l v a l u e o f s a m p l e sT o t a l 0% of 182.7 on 002 as as a 8 - 10 1253 B 004 is a S&P 500 ( 005 MS to 12% 7% 5% 4% 003 r. 858 952 953 1858 887 900 929 989 887 o by 44,000 in 00 2003) $20.9 2003) $0, 04) $9, 2004) 2,201 &D as a of 10% is a s . 49) ($ of 988, 000 EO 001 . J. 42) ($ 002 (52) ($ 997 . r. (48) ($ 993 . 63) ($ 995 004 - 999 001 150 on MS 300 MS 0 on &D &D &P or 2F 3, 2003 385 5, 2001 001 4.4 70 (of , 2001 7.8 1.5 5 , 2001 in 203 in 003 $2002 $2001 $,827 2,266 2,101 2006 ,467 1,890 1,171 2011 34 857 1,112 1997 05 727 592 2004 57 586 487 2011 44 455 68 2013 70 426 413 2003 24 246 269 2004 R 395 297 230 2003 R 354 443 515 2008 03 300 63 1997 83 25 009 C 267 262 240 2001 08 262 240 2007 R 118 184 250 2000 8 221 234 2003 8 017 5 53 297 2001 017 $ 2004 3($ 2003 3$ 24% 98 787 0% 208 908 694 % 5 243 238 28% 77 245 2% 59 241 182 5% 62 157 95 82% 3 236 % 4 69 65 3% 64 165 101 C 18% 10 67 57 72% 67 106 39 ,852 2,739 $2,827 003 (of in 006 $2,467 003 (of S 011 $934 003 (of 997 no 002 U 003 u m b e r o f C o m p o u n a s e I Ph a s e I I Ph a s e I I IN u m b e r o f C o m p o u n I) I) I, II I 1% 71% 75%11% 10%8%10% 10% 10%8% 9% 7%0%20%40%60%80%100%2003 2002 2001O t h e rN u t r i t i o NP h a r m a c e u t i c a l 2003 2003 2% 63%65%24% 22%20%6% 7% 7%8% 8% 7%0%20%40%60%80%100%2003 2002 2001Pa ci f i cO t h e r W e s t e e m i s p h e ro p e , M i d d l s t a n d A f ri n i t e d St a t e G a r k e t i n g , S & & & t h e r 2003) R&D as a 0$ 5 , 0 0 0$ 1 0 , 0 0 0$ 1 5 , 0 0 0$ 2 0 , 0 0 0$ 2 5 , 0 0 02004( t t m )2003 2002 2001 2000 19990%10%20%30%40%50%S a l e s % R & D o f S a l e as 19, 2004: $2 $2 $ 5,149,227 2,201 iv 004 ($ 2003 $ 2002 $ 2001 $ 2000 $ MS MS 004 (2003 2002 2001 2000 of $ 21,703 20,894 18,106 18,044 17,695 $ 2,249 3,106 2,067 1,871 3,686 $ 3,614 4,971 3,125 2,445 5,355 $ 30,176 27,391 25,022 27,864 17,921 $ 19,513 17,605 16,266 18,